SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand 
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute 
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
REDWOOD CITY, Calif., March 02, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2016 financial results after market close on Thursday, March 9, 2017. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.
| Live Call: | U.S. | 855 890 8665 |
| International | 720 634 2938 | |
| Passcode | 77904180 | |
| Live Webcast: | Codexis IR Website | |
| The webcast will be archived for 30 days. | ||
| Replay: | U.S. | 855 859 2056 |
| International | 404 537 3406 | |
| Passcode | 77904180 | |
| The replay will be available for 48 hours | ||
About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.
CONTACTS:
Investors
LHA
Jody Cain, 310 691 7100
[email protected]
Media
That’s Nice
Guy Tiene, 212 366 4455
[email protected]
